Cargando…
α7 nicotinic acetylcholine receptor-mediated neuroprotection against dopaminergic neuron loss in an MPTP mouse model via inhibition of astrocyte activation
BACKGROUND: Although evidence suggests that the prevalence of Parkinson’s disease (PD) is lower in smokers than in non-smokers, the mechanisms of nicotine-induced neuroprotection remain unclear. Stimulation of the α7 nicotinic acetylcholine receptor (α7-nAChR) seems to be a crucial mechanism underly...
Autores principales: | Liu, Yuan, Hu, Jun, Wu, Jie, Zhu, Chenlei, Hui, Yujian, Han, Yaping, Huang, Zuhu, Ellsworth, Kevin, Fan, Weimin |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3416733/ https://www.ncbi.nlm.nih.gov/pubmed/22624500 http://dx.doi.org/10.1186/1742-2094-9-98 |
Ejemplares similares
-
Neural circuits and nicotinic acetylcholine receptors mediate the cholinergic regulation of midbrain dopaminergic neurons and nicotine dependence
por: Xiao, Cheng, et al.
Publicado: (2019) -
Neuroprotective Effects of Tetramethylpyrazine against Dopaminergic Neuron Injury in a Rat Model of Parkinson's Disease Induced by MPTP
por: Lu, Chen, et al.
Publicado: (2014) -
Discovery of a Necroptosis Inhibitor Improving Dopaminergic Neuronal Loss after MPTP Exposure in Mice
por: Oliveira, Sara R., et al.
Publicado: (2021) -
Alpha6-Containing Nicotinic Acetylcholine Receptors Mediate Nicotine-Induced Structural Plasticity in Mouse and Human iPSC-Derived Dopaminergic Neurons
por: Collo, Ginetta, et al.
Publicado: (2018) -
Mirtazapine exerts astrocyte-mediated dopaminergic neuroprotection
por: Kikuoka, Ryo, et al.
Publicado: (2020)